DK0993306T3 - Oligomeric, perfluoroalkyl-containing compounds, processes for their preparation and their use in NMR diagnostics - Google Patents

Oligomeric, perfluoroalkyl-containing compounds, processes for their preparation and their use in NMR diagnostics

Info

Publication number
DK0993306T3
DK0993306T3 DK98937424T DK98937424T DK0993306T3 DK 0993306 T3 DK0993306 T3 DK 0993306T3 DK 98937424 T DK98937424 T DK 98937424T DK 98937424 T DK98937424 T DK 98937424T DK 0993306 T3 DK0993306 T3 DK 0993306T3
Authority
DK
Denmark
Prior art keywords
perfluoroalkyl
oligomeric
processes
preparation
containing compounds
Prior art date
Application number
DK98937424T
Other languages
Danish (da)
Inventor
Johannes Dr Platzek
Ulrich Dr Niedballa
Bernd Dr Raduechel
Wolfgang Dr Schlecker
Hanns-Joachim Dr Weinmann
Thomas Dr Frenzel
Bernd Dr Misselwitz
Wolfgang Dr Ebert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0993306T3 publication Critical patent/DK0993306T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/122—Macromolecular compounds dimers of complexes or complex-forming compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Perfluoroalkylated oligomer compounds have the general formula (I) A-R<F>, in which A is a molecular fraction with 2-6 metal complexes bonded to an annular structural chain directly or via a linker with a nitrogen atom; and R<F> is a perfluorinated, straight-chain or branched carbon chain of formula CnF2nE, in which is a terminal fluorine, chlorine, bromine, iodine or hydrogen atom and n equals 4-30. These compounds are valuable for diagnosis, in particular as in-vivo contrasting agents.
DK98937424T 1997-07-03 1998-05-28 Oligomeric, perfluoroalkyl-containing compounds, processes for their preparation and their use in NMR diagnostics DK0993306T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19729013A DE19729013A1 (en) 1997-07-03 1997-07-03 Oligomeric, perfluoroalkyl-containing compounds, processes for their preparation and their use in NMR diagnostics
PCT/EP1998/003143 WO1999001161A1 (en) 1997-07-03 1998-05-28 Perfluoroalkylated oligomer compounds, process for preparing the same and their use in nmr diagnosis

Publications (1)

Publication Number Publication Date
DK0993306T3 true DK0993306T3 (en) 2003-11-03

Family

ID=7834922

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98937424T DK0993306T3 (en) 1997-07-03 1998-05-28 Oligomeric, perfluoroalkyl-containing compounds, processes for their preparation and their use in NMR diagnostics

Country Status (11)

Country Link
EP (1) EP0993306B1 (en)
JP (1) JP2002507977A (en)
AT (1) ATE249246T1 (en)
AU (1) AU8623698A (en)
DE (2) DE19729013A1 (en)
DK (1) DK0993306T3 (en)
ES (1) ES2206966T3 (en)
PT (1) PT993306E (en)
TW (1) TW510903B (en)
WO (1) WO1999001161A1 (en)
ZA (1) ZA985895B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1088559A3 (en) * 1999-09-29 2002-10-02 INSTITUT FÜR DIAGNOSTIKFORSCHUNG GmbH AN DER FREIEN UNIVERSITÄT BERLIN Galenic formulations
DE19948650A1 (en) * 1999-09-29 2001-07-19 Diagnostikforschung Inst Contrast agent formulations containing perfluoroalkylated dye and other perfluoroalkylated compound, having high organ specificity, especially for lymph nodes, useful e.g. in fluorescence or near infrared diagnosis
DE19948651B4 (en) * 1999-09-29 2006-10-05 Schering Ag Galenic formulations containing para and diamagnetic perfluorinated compounds, their preparation and use
US6641797B2 (en) 2000-08-11 2003-11-04 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use
DE10040380B4 (en) * 2000-08-11 2006-03-09 Schering Ag MRI contrast agent for visualization of plaque, lymph nodes, infarcted and necrotic tissue or both necrosis and tumors, comprising perfluoroalkylated metal complex having specific micelle forming properties
US6676928B2 (en) 2000-08-11 2004-01-13 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use
DE10040381C1 (en) * 2000-08-11 2002-06-06 Schering Ag Perfluoroalkyl-containing complexes with sugar residues, process for their preparation and their use
US6818203B2 (en) * 2000-08-11 2004-11-16 Schering Aktiengesellschaft Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses
DE10066210B4 (en) * 2000-08-11 2008-02-28 Bayer Schering Pharma Ag Use of perfluoroalkyl-containing metal complexes as contrast agents in MR imaging for plaque imaging
DE10040858C2 (en) * 2000-08-11 2003-12-18 Schering Ag Perfluoroalkyl-containing complexes with polar residues, process for their preparation and their use
DK2022787T3 (en) * 2000-09-29 2013-02-25 Genzyme Corp Process for the preparation of nitrogen-containing cyclic polyamines with N-1-protected N-ring and products thereof
US7344704B2 (en) 2002-07-10 2008-03-18 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
DE10231799B4 (en) * 2002-07-10 2006-10-05 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast agents in MR imaging for the presentation of intravascular thrombi
SI1836239T1 (en) 2005-01-13 2009-04-30 Cinv Ag Composite materials containing carbon nanoparticles
DE102006021495A1 (en) * 2006-05-09 2007-11-15 Bayer Schering Pharma Ag Use of metal chelate containing perfluorinated alkyl-residue, chelator-residue and metal ion equivalent to the atomic number, for the production of diagnostic agent for representation of amyloid-containing plaques
US7887835B2 (en) * 2006-09-19 2011-02-15 Fujifilm Corporation Compound comprising a fluorine-substituted alkyl group and a liposome contrast medium comprising the compound
DE102006049821A1 (en) 2006-10-18 2008-04-24 Bayer Schering Pharma Aktiengesellschaft New, well tolerated metal chelates, for use as radiodiagnostic, radiotherapeutic or NMR and X-ray diagnostic agents, contain chelator and perfluorinated polyethylene glycol residues
DE102007015598A1 (en) * 2007-03-29 2008-10-02 Heinrich-Heine-Universität Düsseldorf Use of fluorochemical compounds for diagnostic purposes using imaging techniques
DE102008045937B4 (en) * 2008-04-11 2017-01-26 Johannes-Gutenberg-Universität Mainz Radiopharmaceutical of a metal ion and a label precursor and use of the radiopharmaceutical
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
CA3019952A1 (en) 2016-02-04 2017-08-10 Curis, Inc. Mutant smoothened and methods of using the same
CA3044877A1 (en) 2016-11-28 2018-05-31 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
SG11202104657RA (en) 2018-11-23 2021-06-29 Bayer Ag Formulation of contrast media and process of preparation thereof
CN109867635A (en) * 2019-02-14 2019-06-11 华东师范大学 A kind of T1 type micella magnetic resonance imaging contrast and preparation method thereof
CN110407887A (en) * 2019-04-25 2019-11-05 上海大学 Complex, preparation method and its application containing positive quadrivalent iron or manganese complex ion

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4317588C2 (en) * 1993-05-24 1998-04-16 Schering Ag Macrocyclic metal complexes containing fluorine, process for their preparation and their use
DE19521945A1 (en) * 1995-06-12 1996-12-19 Schering Ag Cascade polymers with iodoaromatics
DE19525924A1 (en) * 1995-07-04 1997-01-09 Schering Ag Cascade polymer complexes, processes for their preparation and pharmaceutical compositions containing them
DE19603033A1 (en) * 1996-01-19 1997-07-24 Schering Ag Perfluoroalkyl-containing metal complexes, processes for their preparation and their use in NMR diagnostics
DE19608278A1 (en) * 1996-02-23 1997-08-28 Schering Ag Pharmaceutical compositions containing perfluoroalkyl-containing metal complexes, and their use in tumor therapy and interventional radiology

Also Published As

Publication number Publication date
JP2002507977A (en) 2002-03-12
WO1999001161A1 (en) 1999-01-14
AU8623698A (en) 1999-01-25
ATE249246T1 (en) 2003-09-15
DE59809579D1 (en) 2003-10-16
ES2206966T3 (en) 2004-05-16
DE19729013A1 (en) 1999-02-04
EP0993306A1 (en) 2000-04-19
ZA985895B (en) 1999-04-16
PT993306E (en) 2003-11-28
TW510903B (en) 2002-11-21
EP0993306B1 (en) 2003-09-10

Similar Documents

Publication Publication Date Title
DK0993306T3 (en) Oligomeric, perfluoroalkyl-containing compounds, processes for their preparation and their use in NMR diagnostics
Micklitz et al. Characterization of a novel. mu. 4-peroxide tetrairon unit of possible relevance to intermediates in metal-catalyzed oxidations of water to dioxygen
TR199903172T2 (en) Highly durable cryogenic welding joints.
YU72203A (en) Conjugate of hydroxyalkyl starch and an active agent
NO20051270L (en) Fused benzene derivative and use
DE3573725D1 (en) Method of preparing a chlorinated, brominated, radiobrominated, iodinated and/or radioiodinated, aromatic or heteroaromatic compound, as well as a kit for preparing a diagnostic composition on the basis of this compound
DE69612835T2 (en) TRICYCLIC CONNECTIONS
FR2369330A1 (en) THERMOACTIVABLE COMPOSITIONS USEFUL AS ADHESIVES
DK0882010T3 (en) Pharmaceutical agents containing perfluoroalkyl-containing metal complexes
Kuninobu et al. Manganese-catalyzed synthesis of hydantoin derivatives from terminal alkynes and isocyanates
BRPI0711100A2 (en) trifluoromethylation reaction reagent
EA200500897A1 (en) METHOD OF OBTAINING PETROPHENONS
ES2192852T3 (en) PROCESS OF OBTAINING 3-ARIL-BENZOFURANONAS.
WO2003004443A3 (en) Catalyst system for rendering organic propellants hypergolic with hydrogen peroxide
Chou et al. A convergent strategy for synthesis of Erythrina alkaloids
Kumar HbA/H2O2: an efficient biomimetic catalytic system for the oxidation of sulfides to sulfoxides
AU2002314026A1 (en) Method for the production of zolpidem
Sutherland et al. Heterometallic Polyhydride Raft Formation: A Comparison of Syntheses using Alkoxides of Copper and Gold
Waisser et al. New groups of potential antituberculotics: bis (1-aryltetrazol-5-yl) disulfides. structure activity relationship
NO20033029D0 (en) Process for the preparation of hydrocarbons with a modified carbon skeleton
FR3118707B1 (en) Solid composition for dyeing and/or lightening keratinous fibers
Lafrance Investigations of metal carbonyl complexes as potential catalysts for the alternating co-polymerization of imine and carbon monoxide into polypeptides.
RO115257B1 (en) Process for preparing 2, 3, 5, 6 - tetrachloropyridine
Zagorin Moving to the Big Citi.
JP3432280B2 (en) Method for producing aromatic amine compound